United States VVZ-149 Market Report 2022: A New Mechanism-Based Non-Narcotic and Non-NSAID Analgesic by Vivozon - Emerging Drug Insights and Market Forecasts to 2032
March 07, 2023 10:28 ET
|
Research and Markets
Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "United States VVZ-149 Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. ...
The bioavailability enhancement services market is projected to grow at an annualized rate of 11.12% during the period 2021-2035, claims Roots Analysis
February 08, 2023 09:05 ET
|
Roots Analysis
London, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Bioavailability Enhancement Technologies and Services Market (2nd Edition), 2022-2035” report to its list of...
Global Bio analytical Testing Services Market to Surpass US$ 7,749.5 Million by 2030, Says Coherent Market Insights (CMI)
January 24, 2023 09:15 ET
|
CMI
Burlingame, Jan. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global bio analytical testing services market is estimated to be valued at US$ 3,198.9 million in 2022 and is...
1 Day Fundamentals of Pharmacokinetics Seminar: The Processes that a Drug Undergoes After Administration
December 30, 2022 05:03 ET
|
Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "Full Day Virtual Seminar on Fundamentals of Pharmacokinetics" webinar has been added to ResearchAndMarkets.com's offering.Pharmacokinetics (PK) and...
Insights on the Bioavailability Enhancement Technologies and Services Global Market to 2035 - Industry Trends and Forecasts
December 12, 2022 08:18 ET
|
Research and Markets
Dublin, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The "Bioavailability Enhancement Technologies and Services Market by Drug Class, BCS Classification, Bioavailability Enhancement Approach, Dosage Form and...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution
August 11, 2022 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “The Power of Science to Stop a Killer.” To...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Developing Powerful Tech to Treat Hypertension
August 09, 2022 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+...
Global Ophthalmic Drug Delivery Systems Market (2022 to 2030) - Size, Share & Trends Analysis Report
April 12, 2022 07:48 ET
|
Research and Markets
Dublin, April 12, 2022 (GLOBE NEWSWIRE) -- The "Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report, 2022-2030" report has been added to ResearchAndMarkets.com's...
Global Oral Proteins and Peptides Market to 2032 - by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players and Geography
March 16, 2022 07:43 ET
|
Research and Markets
Dublin, March 16, 2022 (GLOBE NEWSWIRE) -- The "Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key...
Global Drug Bioavailability Enhancement Summit 2022: Two Day Online Program - May 16-17, 2022
March 08, 2022 04:18 ET
|
Research and Markets
Dublin, March 08, 2022 (GLOBE NEWSWIRE) -- The "2022 Global Drug Bioavailability Enhancement Summit" conference has been added to ResearchAndMarkets.com's offering. Are you tasked with improving...